Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Recombinant Origins of Pathogenic and Nonpathogenic Mouse Gammaretroviruses with Polytropic Host Range.

Bamunusinghe D, Liu Q, Plishka R, Dolan MA, Skorski M, Oler AJ, Yedavalli VRK, Buckler-White A, Hartley JW, Kozak CA.

J Virol. 2017 Oct 13;91(21). pii: e00855-17. doi: 10.1128/JVI.00855-17. Print 2017 Nov 1.

2.

Early antibody therapy can induce long-lasting immunity to SHIV.

Nishimura Y, Gautam R, Chun TW, Sadjadpour R, Foulds KE, Shingai M, Klein F, Gazumyan A, Golijanin J, Donaldson M, Donau OK, Plishka RJ, Buckler-White A, Seaman MS, Lifson JD, Koup RA, Fauci AS, Nussenzweig MC, Martin MA.

Nature. 2017 Mar 23;543(7646):559-563. doi: 10.1038/nature21435. Epub 2017 Mar 13.

3.

Long-term passage of Vif-null HIV-1 in CD4+ T cells expressing sub-lethal levels of APOBEC proteins fails to develop APOBEC resistance.

Miyagi E, Kao S, Fumitaka M, Buckler-White A, Plishka R, Strebel K.

Virology. 2017 Apr;504:1-11. doi: 10.1016/j.virol.2017.01.016. Epub 2017 Jan 25.

4.

TRIM5α Resistance Escape Mutations in the Capsid Are Transferable between Simian Immunodeficiency Virus Strains.

Wu F, Kirmaier A, White E, Ourmanov I, Whitted S, Matsuda K, Riddick N, Hall LR, Morgan JS, Plishka RJ, Buckler-White A, Johnson WE, Hirsch VM.

J Virol. 2016 Nov 28;90(24):11087-11095. Print 2016 Dec 15.

5.

Enhanced antagonism of BST-2 by a neurovirulent SIV envelope.

Matsuda K, Chen CY, Whitted S, Chertova E, Roser DJ, Wu F, Plishka RJ, Ourmanov I, Buckler-White A, Lifson JD, Strebel K, Hirsch VM.

J Clin Invest. 2016 Jun 1;126(6):2295-307. doi: 10.1172/JCI83725. Epub 2016 May 9.

6.

Sequence Diversity, Intersubgroup Relationships, and Origins of the Mouse Leukemia Gammaretroviruses of Laboratory and Wild Mice.

Bamunusinghe D, Naghashfar Z, Buckler-White A, Plishka R, Baliji S, Liu Q, Kassner J, Oler AJ, Hartley J, Kozak CA.

J Virol. 2016 Mar 28;90(8):4186-98. doi: 10.1128/JVI.03186-15. Print 2016 Apr.

7.

Simian Immunodeficiency Virus SIVagm Efficiently Utilizes Non-CCR5 Entry Pathways in African Green Monkey Lymphocytes: Potential Role for GPR15 and CXCR6 as Viral Coreceptors.

Riddick NE, Wu F, Matsuda K, Whitted S, Ourmanov I, Goldstein S, Goeken RM, Plishka RJ, Buckler-White A, Brenchley JM, Hirsch VM.

J Virol. 2015 Dec 9;90(5):2316-31. doi: 10.1128/JVI.02529-15.

8.

The Expression of Functional Vpx during Pathogenic SIVmac Infections of Rhesus Macaques Suppresses SAMHD1 in CD4+ Memory T Cells.

Shingai M, Welbourn S, Brenchley JM, Acharya P, Miyagi E, Plishka RJ, Buckler-White A, Kwong PD, Nishimura Y, Strebel K, Martin MA.

PLoS Pathog. 2015 May 21;11(5):e1004928. doi: 10.1371/journal.ppat.1004928. eCollection 2015 May.

9.

TRIM5α restriction affects clinical outcome and disease progression in simian immunodeficiency virus-infected rhesus macaques.

Wu F, Ourmanov I, Riddick N, Matsuda K, Whitted S, Plishka RJ, Buckler-White A, Starost MF, Hirsch VM.

J Virol. 2015 Feb;89(4):2233-40. doi: 10.1128/JVI.02978-14. Epub 2014 Dec 3.

10.

Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques.

Shingai M, Donau OK, Plishka RJ, Buckler-White A, Mascola JR, Nabel GJ, Nason MC, Montefiori D, Moldt B, Poignard P, Diskin R, Bjorkman PJ, Eckhaus MA, Klein F, Mouquet H, Cetrulo Lorenzi JC, Gazumyan A, Burton DR, Nussenzweig MC, Martin MA, Nishimura Y.

J Exp Med. 2014 Sep 22;211(10):2061-74. doi: 10.1084/jem.20132494. Epub 2014 Aug 25.

11.

Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia.

Shingai M, Nishimura Y, Klein F, Mouquet H, Donau OK, Plishka R, Buckler-White A, Seaman M, Piatak M Jr, Lifson JD, Dimitrov DS, Nussenzweig MC, Martin MA.

Nature. 2013 Nov 14;503(7475):277-80. doi: 10.1038/nature12746. Epub 2013 Oct 30.

12.

TRIM5 alpha drives SIVsmm evolution in rhesus macaques.

Wu F, Kirmaier A, Goeken R, Ourmanov I, Hall L, Morgan JS, Matsuda K, Buckler-White A, Tomioka K, Plishka R, Whitted S, Johnson W, Hirsch VM.

PLoS Pathog. 2013;9(8):e1003577. doi: 10.1371/journal.ppat.1003577. Epub 2013 Aug 22.

13.

Laser capture microdissection assessment of virus compartmentalization in the central nervous systems of macaques infected with neurovirulent simian immunodeficiency virus.

Matsuda K, Brown CR, Foley B, Goeken R, Whitted S, Dang Q, Wu F, Plishka R, Buckler-White A, Hirsch VM.

J Virol. 2013 Aug;87(16):8896-908. doi: 10.1128/JVI.00874-13. Epub 2013 May 29.

14.

Most rhesus macaques infected with the CCR5-tropic SHIV(AD8) generate cross-reactive antibodies that neutralize multiple HIV-1 strains.

Shingai M, Donau OK, Schmidt SD, Gautam R, Plishka RJ, Buckler-White A, Sadjadpour R, Lee WR, LaBranche CC, Montefiori DC, Mascola JR, Nishimura Y, Martin MA.

Proc Natl Acad Sci U S A. 2012 Nov 27;109(48):19769-74. doi: 10.1073/pnas.1217443109. Epub 2012 Nov 5.

15.

Degenerate recognition of MHC class I molecules with Bw4 and Bw6 motifs by a killer cell Ig-like receptor 3DL expressed by macaque NK cells.

Maloveste SM, Chen D, Gostick E, Vivian JP, Plishka RJ, Iyengar R, Kruthers RL, Buckler-White A, Brooks AG, Rossjohn J, Price DA, Lafont BA.

J Immunol. 2012 Nov 1;189(9):4338-48. doi: 10.4049/jimmunol.1201360. Epub 2012 Oct 5.

16.

Development of neurological disease is associated with increased immune activation in simian immunodeficiency virus-infected macaques.

Dang Q, Whitted S, Goeken RM, Brenchley JM, Matsuda K, Brown CR, Lafont BA, Starost MF, Iyengar R, Plishka RJ, Buckler-White A, Hirsch VM.

J Virol. 2012 Dec;86(24):13795-9. doi: 10.1128/JVI.02174-12. Epub 2012 Oct 3.

17.

Sequential evolution and escape from neutralization of simian immunodeficiency virus SIVsmE660 clones in rhesus macaques.

Wu F, Ourmanov I, Kuwata T, Goeken R, Brown CR, Buckler-White A, Iyengar R, Plishka R, Aoki ST, Hirsch VM.

J Virol. 2012 Aug;86(16):8835-47. doi: 10.1128/JVI.00923-12. Epub 2012 Jun 13.

18.

Correction of a carboxyl terminal simian immunodeficiency virus Nef frameshift mutation restores virus replication in macaques.

Zheng Y, Ourmanov I, Goeken RM, Whitted S, Brown CR, Buckler-White A, Iyengar R, Plishka RJ, Hirsch VM.

Virology. 2010 Jun 5;401(2):207-14. doi: 10.1016/j.virol.2010.02.026. Epub 2010 Mar 19.

19.

APOBEC3G-independent reduction in virion infectivity during long-term HIV-1 replication in terminally differentiated macrophages.

Miyagi E, Schwartzkopff F, Plishka R, Buckler-White A, Clouse KA, Strebel K.

Virology. 2008 Sep 30;379(2):266-74. doi: 10.1016/j.virol.2008.06.033. Epub 2008 Aug 3.

20.

Adaptive evolution of simian immunodeficiency viruses isolated from 2 conventional-progressor macaques with encephalitis.

Dang Q, Goeken RM, Brown CR, Plishka RJ, Buckler-White A, Byrum R, Foley BT, Hirsch VM.

J Infect Dis. 2008 Jun 15;197(12):1695-700. doi: 10.1086/588671.

21.

A rapid progressor-specific variant clone of simian immunodeficiency virus replicates efficiently in vivo only in the absence of immune responses.

Kuwata T, Byrum R, Whitted S, Goeken R, Buckler-White A, Plishka R, Iyengar R, Hirsch VM.

J Virol. 2007 Sep;81(17):8891-904. Epub 2007 Jun 27.

22.

The locus encoding an oligomorphic family of MHC-A alleles (Mane-A*06/Mamu-A*05) is present at high frequency in several macaque species.

Lafont BA, McGraw CM, Stukes SA, Buckler-White A, Plishka RJ, Byrum RA, Hirsch VM, Martin MA.

Immunogenetics. 2007 Mar;59(3):211-23. Epub 2007 Jan 26.

PMID:
17256149
23.

Infectious molecular clones from a simian immunodeficiency virus-infected rapid-progressor (RP) macaque: evidence of differential selection of RP-specific envelope mutations in vitro and in vivo.

Kuwata T, Dehghani H, Brown CR, Plishka R, Buckler-White A, Igarashi T, Mattapallil J, Roederer M, Hirsch VM.

J Virol. 2006 Feb;80(3):1463-75.

24.

Immunodeficiency in the absence of high viral load in pig-tailed macaques infected with Simian immunodeficiency virus SIVsun or SIVlhoest.

Beer BE, Brown CR, Whitted S, Goldstein S, Goeken R, Plishka R, Buckler-White A, Hirsch VM.

J Virol. 2005 Nov;79(22):14044-56.

25.
26.

Production of infectious SIVagm from human cells requires functional inactivation but not viral exclusion of human APOBEC3G.

Takeuchi H, Kao S, Miyagi E, Khan MA, Buckler-White A, Plishka R, Strebel K.

J Biol Chem. 2005 Jan 7;280(1):375-82. Epub 2004 Nov 3.

27.

Pig-tailed macaques (Macaca nemestrina) possess six MHC-E families that are conserved among macaque species: implication for their binding to natural killer receptor variants.

Lafont BA, Buckler-White A, Plishka R, Buckler C, Martin MA.

Immunogenetics. 2004 Jun;56(3):142-54. Epub 2004 May 18.

PMID:
15148641
28.

Induction of disease by a molecularly cloned highly pathogenic simian immunodeficiency virus/human immunodeficiency virus chimera is multigenic.

Sadjadpour R, Theodore TS, Igarashi T, Donau OK, Plishka RJ, Buckler-White A, Martin MA.

J Virol. 2004 May;78(10):5513-9.

29.

Immune failure in the absence of profound CD4+ T-lymphocyte depletion in simian immunodeficiency virus-infected rapid progressor macaques.

Hirsch VM, Santra S, Goldstein S, Plishka R, Buckler-White A, Seth A, Ourmanov I, Brown CR, Engle R, Montefiori D, Glowczwskie J, Kunstman K, Wolinsky S, Letvin NL.

J Virol. 2004 Jan;78(1):275-84.

30.

Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophages.

Igarashi T, Donau OK, Imamichi H, Dumaurier MJ, Sadjadpour R, Plishka RJ, Buckler-White A, Buckler C, Suffredini AF, Lane HC, Moore JP, Martin MA.

J Virol. 2003 Dec;77(24):13042-52.

31.

Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: implications for HIV-1 vaccine development.

Nishimura Y, Igarashi T, Haigwood NL, Sadjadpour R, Donau OK, Buckler C, Plishka RJ, Buckler-White A, Martin MA.

Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15131-6. Epub 2003 Nov 19.

32.
33.

Early control of highly pathogenic simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys usually results in long-lasting asymptomatic clinical outcomes.

Igarashi T, Endo Y, Nishimura Y, Buckler C, Sadjadpour R, Donau OK, Dumaurier MJ, Plishka RJ, Buckler-White A, Martin MA.

J Virol. 2003 Oct;77(20):10829-40.

34.

Characterization of pig-tailed macaque classical MHC class I genes: implications for MHC evolution and antigen presentation in macaques.

Lafont BA, Buckler-White A, Plishka R, Buckler C, Martin MA.

J Immunol. 2003 Jul 15;171(2):875-85.

35.
36.
37.

Rapid and irreversible CD4+ T-cell depletion induced by the highly pathogenic simian/human immunodeficiency virus SHIV(DH12R) is systemic and synchronous.

Igarashi T, Brown CR, Byrum RA, Nishimura Y, Endo Y, Plishka RJ, Buckler C, Buckler-White A, Miller G, Hirsch VM, Martin MA.

J Virol. 2002 Jan;76(1):379-91.

39.

Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination.

Barouch DH, Santra S, Kuroda MJ, Schmitz JE, Plishka R, Buckler-White A, Gaitan AE, Zin R, Nam JH, Wyatt LS, Lifton MA, Nickerson CE, Moss B, Montefiori DC, Hirsch VM, Letvin NL.

J Virol. 2001 Jun;75(11):5151-8.

40.

Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous Simian/human immunodeficiency virus infection in pigtailed macaques.

Cho MW, Kim YB, Lee MK, Gupta KC, Ross W, Plishka R, Buckler-White A, Igarashi T, Theodore T, Byrum R, Kemp C, Montefiori DC, Martin MA.

J Virol. 2001 Mar;75(5):2224-34.

41.
42.

Wide range of viral load in healthy african green monkeys naturally infected with simian immunodeficiency virus.

Goldstein S, Ourmanov I, Brown CR, Beer BE, Elkins WR, Plishka R, Buckler-White A, Hirsch VM.

J Virol. 2000 Dec;74(24):11744-53.

43.

Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus.

Endo Y, Igarashi T, Nishimura Y, Buckler C, Buckler-White A, Plishka R, Dimitrov DS, Martin MA.

J Virol. 2000 Aug;74(15):6935-45.

44.

Emergence of a highly pathogenic simian/human immunodeficiency virus in a rhesus macaque treated with anti-CD8 mAb during a primary infection with a nonpathogenic virus.

Igarashi T, Endo Y, Englund G, Sadjadpour R, Matano T, Buckler C, Buckler-White A, Plishka R, Theodore T, Shibata R, Martin M.

Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14049-54.

45.

An internally controlled virion PCR for the measurement of HIV-1 RNA in plasma.

Natarajan V, Plishka RJ, Scott EW, Lane HC, Salzman NP.

PCR Methods Appl. 1994 Jun;3(6):346-50.

46.
47.

Morphine treatment increases clonidine binding in brain cell cultures.

Plishka RJ, Neale JH.

Neurosci Lett. 1984 Oct 12;51(2):281-6.

PMID:
6096777

Supplemental Content

Loading ...
Support Center